PA540302

Phospho-Annexin A1 (Tyr21) Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PA540302-Each-of-1 In Stock ₹ 47,036.50

PA540302 - Each of 1

₹ 47,036.50

In Stock

Quantity

1

Base Price: ₹ 47,036.50

GST (18%): ₹ 8,466.57

Total Price: ₹ 55,503.07

Antigen

Phospho-Annexin A1 (Tyr21)

Classification

Polyclonal

Conjugate

Unconjugated

Gene

ANXA1

Gene Alias

ANAX1; Annexin 1 (p35) (Lipocortin 1); annexin A1; Annexin I; annexin I (lipocortin I); annexin-1; ANX1; Anx-1; Anxa1; Anx-A1; C430014K04Rik; Calpactin II; calpactin-2; Chromobindin-9; lipocortin 1; lipocortin I; LPC1; Lpc-1; p35; Phospholipase A2 inhibitory protein; RP11-71A24.1

Host Species

Rabbit

Purification Method

Antigen affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

16952, 301

Content And Storage

-20° C, Avoid Freeze/Thaw Cycles

Form

Liquid

Applications

ELISA, Western Blot

Concentration

1 mg/mL

Formulation

PBS with 0.5% BSA, 50% glycerol and 0.02% sodium azide; pH 7.4

Gene Accession No.

P04083, P10107

Gene Symbols

ANXA1

Immunogen

Synthesized peptide derived from human Annexin I around the phosphorylation site of Y21.

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Human, Mouse

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PA540209

--

Img

Thermo Scientific

PA540263

--

Img

Thermo Scientific

PA540198

--

Img

Thermo Scientific

PA540303

--

Img

Thermo Scientific

PA540280

--

Img

Thermo Scientific

PA540214

--

Img

Thermo Scientific

PA540265

--

Img

Thermo Scientific

PA540243

--

Description

  • This antibody is predicted to react with human based on sequence homology
  • Annexin I belongs to a family of Ca (2+) -dependent phospholipid binding proteins that are preferentially located on the cytosolic face of the plasma membrane
  • Annexin I has a molecular mass of 40 kDa, with phospholipase A2 inhibitory activity
  • Since phospholipase A2 is required for the biosynthesis of the potent mediators of inflammation, prostaglandins and leukotrienes, annexin I may have potential anti-inflammatory activity.